首页> 外文期刊>The journal of asthma >Lack of asthma arid rhinitis control in general practitioner-managed patients prescribed fixed-dose combination therapy in Australia
【24h】

Lack of asthma arid rhinitis control in general practitioner-managed patients prescribed fixed-dose combination therapy in Australia

机译:缺乏哮喘干旱鼻炎对澳大利亚规定的固定剂量组合治疗

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Objectives; The first aim of the study (i) assess the current asthma status of general-practitioner-managed patients receiving regular fixed-dose combination inhaled corticosteroid and long-acting beta(2) agonist (FDC ICS/LABA) therapy and (ii) explore patients' perceptions of asthma control and attitudes/behaviors regarding preventer inhaler use. Methods: A cross-sectional observational study of Australian adults with a current physician diagnosis of asthma receiving = 2 prescriptions of FDC ICS/LABA therapy in the previous year, who were recruited through general practice to receive a structured in-depth asthma review between May 2012 and January 2014. Descriptive statistics and Chi-Square tests for independence were used for associations across asthma control levels. Results: Only 11.5% of the patients had controlled asthma based on guideline-defined criteria. Contrarily, 66.5% of the patients considered their asthma to be well controlled. Incidence of acute asthma exacerbations in the previous year was 26.5% and 45.6% of the patients were without a diagnosis of rhinitis. Asthma medication use and inhaler technique were sub-optimal; only 41.0% of the preventer users reported everyday use, The side effects of medication were common and more frequently reported among uncontrolled and partially controlled patients. Conclusions: The study revealed the extent to which asthma management needs to be improved in this patient cohort and the numerous unmet needs regarding the current state of asthma care. Not only there is a need for continuous education of patients, but also education of health care practitioners to better understand the way in which patient's perceptions impact on asthma management practices, incorporating these findings into clinical decision making.
机译:目标;研究的第一个目的(i)评估接受定期固定剂组合吸入皮质类固醇和长效β(2)激动剂(FDC ICS / Laba)治疗和(ii)探索患者对预防吸入器使用的哮喘控制和态度/行为的看法。方法:澳大利亚成年人的横截面观测研究,具有目前的哮喘接受诊断& =前一年的2例FDC IC / Laba疗法处方,通过一般做法招聘了,以获得结构化的深入哮喘审查2012年5月至2014年1月期间。用于独立的描述性统计和Chi-Square测试用于哮喘控制水平的关联。结果:仅11.5%的患者基于指南鉴定的标准控制哮喘。相反,66.5%的患者认为他们的哮喘是良好的控制。前一年中急性哮喘恶化的发病率为26.5%,45.6%的患者没有诊断鼻炎。哮喘用药和吸入器技术是次优的;只有41.0%的预防用户报告日常使用,药物的副作用是常见的,并且在不受控制和部分控制的患者中更常见的报道。结论:该研究表明,在该患者队列中需要改善哮喘管理的程度,以及关于目前哮喘护理状态的无需需求。不仅需要持续的患者教育,而且还需要卫生保健从业者的教育,以更好地了解患者对哮喘管理实践影响的方式,将这些发现纳入临床决策。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号